熱門資訊> 正文
Integra LifeSciences任命新的首席医疗官
2025-09-22 21:06
- 纳比特(NA) 0
- 盛大科技(SDA) 0
- 英特格拉生命科學(IART) 0
- Integra LifeSciences (NASDAQ:IART) announced on Monday the appointment of Raymond Turner as its new corporate vice president and chief medical officer.
- Turner brings more than 20 years of experience in clinical operations, having held senior leadership positions at some of the world’s largest global MedTech companies.
- Prior to joining Integra, Turner held various leadership roles at Siemens Healthineers, including his most recent position as the chief medical officer for Siemens Endovascular Robotics. Prior to this, he was a medical director for Cerenovus, a Johnson & Johnson MedTech company.
More on Integra LifeSciences Holdings Corporation
- Integra LifeSciences Still Recovering From Self-Inflicted Wounds
- Integra LifeSciences Holdings Corporation (IART) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- Integra LifeSciences Holdings Corporation (IART) Q2 2025 Earnings Call Transcript
- Integra recalls MicroMyst Applicators for sterilization concerns: FDA
- Seeking Alpha’s Quant Rating on Integra LifeSciences Holdings Corporation
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
